MedTrace Logo

VIRTUAL REALITY TECHNOLOGY FOR CEREBRAL PALSY

NCT05872217 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-05-24

No results posted yet for this study

Summary

The VRapeutic (Full-immersive game-based therapy) is new therapeutic Egyptian software. It has the potential to provide intensive, repetitive, and task-oriented training. It may increase children's motivation, enjoyment, active social participation. Children with UCP may experience varieties of associated health conditions as difficulty of movement, instability of postural balance, difficulty of motor planning and control which impact on UE function.

Conditions

  • Cerebral Palsy

Interventions

OTHER

conventional upper extremity therapeutic program

• This group will receive conventional UE therapeutic program for 60 minutes each session including: * Exercises based on neurodevelopment technique . * Gentle manual stretching for tight muscles of the affected UE from proximal to distal segments for 5minutes. * Weight-bearing exercises for 10minutes for UE from prone lying, side sitting and quadriped position. * Strengthening exercises for 10 minutes for muscles of UE as push-up from prone lying position, quadriped position, 3 point exercise, walk on hand, climbing, hanging on a bar, squeeze stress balls, cutting usescissors to strengthen hand . * Goal directed training for 10 minutes the child will practice specific tasks that are needed for everyday life and which they find a challenge like (3 daily tasks as cleaning mirror, dressing and undressing, using pen and ruler to draw shapes, brushing teeth . * Fine motor activities as reach, grasp, carry and release activities.

OTHER

full immersive VRapeutic software gaming technology

• Children in this group will receive the same conventional UE therapeutic program as control group for 60 minutes in addition to virtual reality session using VRapeutic software gaming technology, Archeeko module (figure 3) for 30 min/3 sessions/week for 8 weeks

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Eman I Elhadidy · Cairo University

  • Maya G Abd elwahab · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2024-01-31
Completion
2024-02-29

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05872217 on ClinicalTrials.gov